Drawing for Serial No. 79209077

USPTO serial 79209077

Serial No. 79209077

Reviewed by CopyMark Law Group

Reg. 5510345Status 700Registered
Filing date
Status date
Registration date
Jul 10, 2018
Examiner
LAMONT, JOHN CHRISTOPHER
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79209077?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles Ho

Charles Ho Barron & Young PLLC5465 Legacy Drive, Suite 650Plano, TX 75024United States

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes, namely, medicines for the treatment of cancer, autoimmune disease and inflammation-related disease; biochemical drug, namely, drugs for the treatment of cancer, autoimmune disease and inflammation-related disease; medicinal drinks; biological preparations for medical purposes, namely, medical preparations for the treatment of cancer, autoimmune disease and inflammation- related disease; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, autoimmune disease and inflammation-related disease; Drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; traditional Chinese medicines, namely, medicinal herbal preparations; diagnostic preparations for medical purposes; drugs for medical purposes, namely, dosage form such as tablets, capsules, and pills for the treatment of cancer, autoimmune disease and inflammation-related diseases; dietetic foods adapted for medical useACTIVE—
035Demonstration of goods; advertising services; business management assistance; organizing exhibitions for commercial or advertising purposes in the field of technological goods and services; provision of an on-line marketplace for buyers and sellers of goods and services; import- export agency services; retail and wholesale store services featuring pharmaceutical, veterinary, and sanitary preparations and medical supplies; retail and wholesale store services featuring pharmaceuticals; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring medical suppliesACTIVE—
042Research and development of new products for others; technical research in the field of pharmaceutical studies and development; quality control for others; product quality testing for others; chemical research; chemistry consultation services; bacteriological research; biological research; conducting clinical trials for others; material testingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 25, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Aug 24, 2025PR71POST REGISTRATION ACTION MAILED - SEC.71—
Dec 30, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 6, 2024ES71TEAS SECTION 71 RECEIVED—
Apr 29, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 29, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 29, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 29, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 29, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 10, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 9, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 23, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 23, 2018FIMPFINAL DISPOSITION PROCESSED—
Oct 10, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 10, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 24, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 24, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2018GPNXNOTIFICATION PROCESSED BY IB—
Apr 17, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 4, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 4, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 4, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 16, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 15, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 14, 2018ALIEASSIGNED TO LIE—
Mar 1, 2018NREVNOTICE OF REVIVAL - E-MAILED—
Mar 1, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2018PETGPETITION TO REVIVE-GRANTED—
Mar 1, 2018PROATEAS PETITION TO REVIVE RECEIVED—
Feb 12, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 12, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 17, 2018MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 17, 2018ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 8, 2017RFNTREFUSAL PROCESSED BY IB—
Jun 16, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 16, 2017RFRRREFUSAL PROCESSED BY MPU—
Jun 10, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 7, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 6, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2017DOCKASSIGNED TO EXAMINER—
Jun 6, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 1, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance